Latest News of GPCR
Septerna Poised For Biopharma Breakthrough: Analysts Cite GPCR Innovation And 2025 Milestones
By Yahoo! Finance |
2 days ago
Cantor analyst Josh Schimmer and JP Morgan analyst Eric Joseph initiated coverage on biopharma company Septerna (SEPN) with an Overweight rating. Schimmer highlights SEPN's innovative GPCR-targeting p...
Is Structure Therapeutics Inc. (GPCR) the Best Young Stock To Buy Now?
By Yahoo! Finance |
1 month ago
The article discusses the market trends and investment strategies amidst volatility, focusing on the performance of small-cap vs. large-cap stocks. Analysts emphasize a balanced approach, with insight...
Companies Like Structure Therapeutics (NASDAQ:GPCR) Are In A Position To Invest In Growth
By Yahoo! Finance |
3 months ago
Investing in unprofitable businesses like biotech and mining exploration companies can be profitable, but risks exist. Analyzing Structure Therapeutics, its cash burn rate is low compared to cash rese...
-
Tectonic bets on GPCR heart failure drug following reverse merger with Avrobio
By Yahoo! Finance | 4 months agoTectonic Therapeutic completes reverse merger with Avrobio, now trading on Nasdaq as Tectonic Therapeutic (TECX). The new company raised $130.7m in a private placement, ensuring cash reserves of $181m...